PTC Therapeutics Inc.PTCT-0.52%decrease; red down pointing triangle said Monday that it would receive a net price of $35,000 annually per patient for Emflaza, the muscular dystrophy drug it acquired ...
PTC Inc. Annual cash flow by MarketWatch. View PTC net cash flow, operating cash flow, operating expenses and cash dividends.
(RTTNews) - PTC Therapeutics, Inc. (PTCT) reported 2021 total unaudited net revenue of approximately $536 million, representing 41% year-over-year growth. Net product revenue was $429 million, 29% ...
PTC Inc. Annual cash flow by MarketWatch. View PTC net cash flow, operating cash flow, operating expenses and cash dividends.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results